Atherosclerosis of the Thoracic Aorta. Further Characterization for Higher Risk of Vascular Events**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

Journal of the American College of Cardiology

Volumn 52, Issue 10, 2008, Pages 862-864

  Cohen, Ariel ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

aortic arch; atherosclerosis; vascular events

Indexed keywords

BLOOD CLOTTING FACTOR; D DIMER; FIBRINOGEN; HOMOCYSTEINE; PROTHROMBIN FRAGMENT F 1.2; THROMBIN; THROMBIN ANTITHROMBIN COMPLEX; UNCLASSIFIED DRUG;

AORTA ARCH; ARTERY CALCIFICATION; ATHEROMA; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CEREBROVASCULAR ACCIDENT; DISEASE MARKER; DISEASE SEVERITY; EDITORIAL; ENDOTHELIAL DYSFUNCTION; HUMAN; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; RISK FACTOR; SURVIVAL; THORACIC AORTA ATHEROSCLEROSIS;

AORTA, THORACIC; AORTIC DISEASES; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; HUMANS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS;

EID: 49949110674     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.04.063     Document Type: Editorial

References (18)

1. Amarenco P., Duyckaerts C., Tzourio C., Henin D., Bousser M.G., and Hauw J.J. The prevalence of ulcerated plaques in the aortic arch in patients with stroke. N Engl J Med 326 (1992) 221-225
2. Tunick P.A., and Kronzon I. Protruding atherosclerotic plaque in the aortic arch of patients with systemic embolization: a new finding seen by transesophageal echocardiography. Am Heart J 120 (1990) 658-660
3. Corti R., Fuster V., Fayad Z.A., et al. Effects of aggressive versus conventional lipid-lowering therapy by simvastatin on human atherosclerotic lesions: a prospective, randomized, double-blind trial with high-resolution magnetic resonance imaging. J Am Coll Cardiol 46 (2005) 106-112
4. Amarenco P., and Cohen A. Atherosclerotic disease of the aortic arch. In: Barnett H.J.M., Mohr J.P., Stein B.M., and Yatsu F.M. (Eds). Stroke: Pathophysiology, Diagnosis and Management. 3rd edition (1998), Churchill Livingstone, New York, NY 895-920
5. Kronzon I., and Tunick P.A. Aortic atherosclerotic disease and stroke. Circulation 114 (2006) 63-75
6. Macleod M.R., Amarenco P., Davis S.M., and Donnan G.A. Atheroma of the aortic arch: an important and poorly recognised factor in the aetiology of stroke. Lancet Neurol 3 (2004) 408-414
7. Amarenco P., Cohen A., Tzourio C., et al. Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N Engl J Med 331 (1994) 1474-1479
8. Cohen A., Tzourio C., Bertrand B., Chauvel C., Bousser M.G., Amarenco P., and FAPS Investigators. Aortic plaque morphology and vascular events: a follow-up study in patients with ischemic stroke. French Study of Aortic Plaques in Stroke. Circulation 96 (1997) 3838-3841
9. The French Study of Aortic Plaques in Stroke Group. Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke. N Engl J Med 334 (1996) 1216-1221
10. Di Tullio M.R., Homma S., Jin Z., and Sacco R.L. Aortic atherosclerosis, hypercoagulability, and stroke: the APRIS (Aortic Plaque and Risk of Ischemic Stroke) study. J Am Coll Cardiol 52 (2008) 855-861
11. Heinzlef O., Abuaf N., Cohen A., and Amarenco P. Recurrent stroke and vascular events in elderly patients with anticardiolipin antibodies: a prospective study. J Neurol 248 (2001) 373-379
12. Ehlermann P., Mirau W., Jahn J., Remppis A., and Sheikhzadeh A. Predictive value of inflammatory and hemostatic parameters, atherosclerotic risk factors, and chest x-ray for aortic arch atheromatosis. Stroke 35 (2004) 34-39
13. Tribouilloy C., Peltier M., Colas L., et al. Fibrinogen is an independent marker for thoracic aortic atherosclerosis. Am J Cardiol 81 (1998) 321-326
14. Konecky N., Malinow M.R., Tunick P.A., et al. Correlation between plasma homocyst(e)ine and aortic atherosclerosis. Am Heart J 133 (1997) 534-540
15. Habara S., Dote K., Kato M., et al. Prediction of left atrial appendage thrombi in non-valvular atrial fibrillation. Eur Heart J 28 (2007) 2217-2222
16. Sen S., Hinderliter A., Sen P.K., et al. Aortic arch atheroma progression and recurrent vascular events in patients with stroke or transient ischemic attack. Circulation 116 (2007) 928-935
17. Mohr J.P., Thompson J.L., Lazar R.M., et al. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med 345 (2001) 1444-1451
18. Sacco R.L., Adams R., Albers G., et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Circulation 113 (2006) e409-e449